Neoplasia
Издатель: Elsevier · ISSN 1476-5586 · 38 статей
- Combined dopamine receptor inhibition and radiotherapy target mesothelioma-initiating cells and increase survival in a mouse model of mesothelioma
- m6A-Regulated Resistance to Immune Checkpoint Blockade in Cancer: Metabolic and RNA-Mediated Niches in the Tumor Microenvironment
- Therapy-Driven Evolution Across Tumor and Host: Linking Resistance, Clonal Hematopoiesis, and Long-Term Treatment Consequences
- ADAMTS9-AS1 and ADRA1D Are Associated with Urea Cycle Activity and Ammonia Stress Responses in Prostate Cancer
- Multi-Scale Invasion-Associated Proliferative Profiling with Spatial Validation Enables Non-Invasive CT-Based Prognosis in Lung Adenocarcinoma
- Transformation of Human Bronchial Epithelial Cells by Estrogen Metabolites: Implications for Lung Cancer in Never-Smokers
- Integrated multi-omics and experimental analyses characterize an IGF2BP3–MMP7-associated pattern in extracellular matrix remodeling and Treg-associated immune suppression in pancreatic adenocarcinoma
- Bidirectional interactions between radiotherapy and antibody-drug conjugates: targetability, toxicity and sequencing
- Characterization of the genomic landscape in liver-only metastatic colorectal cancer
- Enhancing TCR-T cell responses with a TGFβ-specific chimeric antigen receptor
- Single-cell analysis of epithelial transcriptional states identifies stromal associations and candidate targets in colon cancer
- Survival outcomes, prognostic factors, and molecular landscape of early-onset versus late-onset colorectal cancer: a SEER-based study with external validation and transcriptomic profiling
- Obstructive Sleep Apnea and Lung Cancer Risk: A Systematic Review with Meta-Analysis
- The FOXA1-MAOA axis drives prostate cancer progression and comorbid depression via a tumor-immunity-enteric neural network
- An EFHD1-associated ADSC niche modulates treatment response in experimental models of ER-positive breast cancer
- A Dendritic Cell-Related Prognostic Signature in Glioma: A Multi-Omic Framework Integrating Transcriptomics, Single-Cell Profiling, and Clinical Validation
- State- and niche-dependent cancer-associated fibroblasts in gastric cancer: epithelial plasticity and therapeutic implications
- Engineering CAR-T cell therapies for digestive tract cancer: advances, challenges, and strategies to overcome tumor heterogeneity and immunosuppressive barriers
- Ubiquitin-specific proteases and the immune microenvironment in cervical cancer: mechanistic evidence, immunotherapy resistance, and therapeutic perspectives
- Recent advances in cancer-associated fibroblasts in colorectal cancer: functional subtypes, spatiotemporal dynamics and therapeutic targets
- Antigen persistence after antibody-drug conjugates in urothelial carcinoma: implications for CAR-cell target selection
- The landscape of nanotechnology in esophageal squamous cell carcinoma treatment
- RSPO1–LGR4 axis drives cervical cancer progression via activation of the EGFR/Src/ERK/AKT signaling pathway
- An intron retention-derived secreted Endoglin Isoform as a circulating biomarker in pancreatic ductal adenocarcinoma
- Comprehensive multi-omics analysis identifies BTG2 as a potential regulator of radiotherapy response in lung adenocarcinoma
- Tumor-specific super-enhancer drives overexpression of EVI1/MECOM in ovarian cancer
- Targeting the ac4C writer NAT10: unravelling metabolic dependencies and therapeutic opportunities in cancer
- ISR addiction: Co-opting a stress sentinel to fuel tumor resilience and therapy resistance
- Epitranscriptomic regulation contributes to multiple myeloma biology and offers potential therapeutic targets
- Integrated genomic and transcriptomic profiling reveals distinct molecular features of colorectal cancer in an Indian cohort